Home Page -> Clinical Trials

Active Clinical Trials of Antineoplastons

PLEASE NOTE: Many of the complete written protocols can be obtained by clicking on the protocol name. Because the FDA requires that protocols be frequently updated and amended, the protocols on this Internet site may differ in some details from the actual protocols currently being used at the Burzynski Clinic. Accordingly, please understand that these protocols are being offered for general informational purposes only. Note the page numbers in the table of contents refer to the original printed versions, not the html ones, which are formatted differently (the content is the same however). Some of the appendicies are not yet included. Others are a separate file. Please follow the link in the protocol to find them, or go to Appendices of Clinical Trials.


  1. ADRENAL GLAND: AD-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CARCINOMA OF THE ADRENAL GLAND; Rev 08/30/00updated
  2. BLADDER: BL-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CARCINOMA OF THE BLADDER; Rev 08/30/00updated
  3. BREAST: BR-10. PROTOCOL FOR RANDOMIZED CONTROLLED TRIAL COMPARING METHOTREXATE TREATMENT ALONE TO THE COMBINATION OF METHOTREXATE AND ANTINEOPLASTON A10; Rev 08/30/00updated
  4. BREAST: BR-12. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CARCINOMA OF THE BREAST; Rev 08/30/00updated
  5. BREAST: BR-14. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 CAPSULES IN ADVANCED BREAST CANCER; Rev 08/30/00updated
  6. CHILDREN WITH BRAIN TUMOR: BT-6. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 INFUSIONS IN CHILDREN WITH HIGH-GRADE GLIOMA; Rev 08/30/00updated
  7. BRAIN TUMOR: BT-7. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN GLIOBLASTOMA MULTIFORME; Rev 08/30/00updated
  8. BRAIN TUMOR: BT-8. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ANAPLASTIC ASTROCYTOMA; Rev 08/30/00updated
  9. BRAIN TUMOR: BT-9. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN BRAIN TUMORS; Rev 08/30/00updated
  10. CHILDREN WITH BRAIN TUMOR: BT-10. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CHILDREN WITH BRAIN TUMORS; Rev 08/30/00updated
  11. BRAIN TUMOR: BT-11. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN BRAIN STEM GLIOMA; Rev 08/30/00updated
  12. CHILDREN WITH BRAIN TUMOR: BT-12. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CHILDREN WITH PRIMITIVE NEUROECTODERMAL TUMORS (PNET); Rev 08/30/00updated
  13. CHILDREN WITH BRAIN TUMOR: BT-13. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CHILDREN WITH LOW- GRADE ASTROCYTOMA; Rev 08/30/00updated
  14. CHILDREN WITH BRAIN TUMOR: BT-14. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CHILDREN WITH RHABDOID TUMOR OF THE CENTRAL NERVOUS SYSTEM; Rev 08/30/00updated
  15. ADULTS WITH BRAIN TUMOR: BT-15. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADULTS WITH ANAPLASTIC ASTROCYTOMA; Rev 08/30/00updated
  16. ADULTS WITH BRAIN TUMOR: BT-16. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADULTS WITH LOW- GRADE ASTROCYTOMA; Rev 08/30/00updated
  17. ADULTS WITH BRAIN TUMOR: BT-17. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADULTS WITH OLIGODENDROGLIOMA; Rev 08/30/00updated
  18. ADULTS WITH BRAIN TUMOR: BT-18. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADULTS WITH MIXED GLIOMA; Rev 08/30/00updated
  19. BRAIN TUMOR: BT-19. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN NEUROFIBROMA AND SCHWANNOMA; Rev 08/30/00updated
  20. BRAIN TUMOR:BT-20. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADULTS WITH GLIOBLASTOMA MULTIFORME; Rev 08/30/00updated
  21. ADULTS WITH BRAIN TUMOR: BT-21. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADULTS WITH PRIMARY MALIGNANT BRAIN TUMORS; Rev 08/30/00updated
  22. CHILDREN WITH BRAIN TUMOR: BT-22. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CHILDREN WITH PRIMARY MALIGNANT BRAIN TUMORS; Rev 08/30/00updated
  23. CHILDREN WITH BRAIN TUMOR: BT-23. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 INFUSIONS IN CHILDREN WITH VISUAL PATHWAY GLIOMA; Rev 08/30/00updated
  24. BRAIN TUMOR: BT-24. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 INFUSIONS IN EPENDYMOMA; Rev 08/30/00updated
  25. BRAIN TUMOR: BT-25. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 INFUSIONS IN CRANIOPHARYNGIOMA; Rev 08/30/00updated
  26. BRAIN TUMOR: BT-26. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 INFUSIONS IN CHOROID PLEXUS NEOPLASM; Rev 08/30/00updated
  27. BRAIN TUMOR: BT-27. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 INFUSIONS IN GERM CELL TUMOR OF THE BRAIN; Rev 08/30/00updated
  28. BRAIN TUMOR: BT-28. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 INFUSIONS IN MENINGIOMA; Rev 08/30/00updated
  29. CAN-1. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN REFRACTORY MALIGNANCIES;Rev 08/30/00updated
  30. COLON: CO-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADENOCARCINOMA OF THE COLON; Rev 08/30/00updated
  31. COLON: CO-3. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 CAPSULES IN ADENOCARCINOMA OF THE COLON; 08/30/00updated
  32. ESOPHAGUS: ES-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADENOCARCINOMA OF THE ESOPHAGUS; Rev 08/30/00updated
  33. HEPATOBLASTOMA: HB-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CHILDREN WITH HEPATOBLASTOMA; Rev 08/30/00updated
  34. PRIMARY LIVER CANCER:HE-2. PHASE II STUDY OF ANTINEOPLASTON A10 IN PRIMARY LIVER CANCER; Rev 08/30/00updated
  35. HEAD AND NECK CARCINOMA: HN-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CARCINOMA OF THE HEAD AND NECK; Rev 08/30/00updated
  36. LUNG, ADENOCARCINOMA: LA-3. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADENOCARCINOMA OF THE LUNG; Rev 08/30/00updated
  37. LUNG CARCINOMA: LA-4. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN LARGE CELL, UNDIFFERENTIATED CARCINOMA OF THE LUNG; Rev 08/30/00updated
  38. LUNG CARCINOMA: LA-5. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN BRONCHIAL ALVEOLAR CARCINOMA OF THE LUNG; Rev 08/30/00updated
  39. LUNG CARCINOMA: LA-6. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN SQUAMOUS CELL CARCINOMA OF THE LUNG; Rev 08/30/00updated
  40. LUNG CARCINOMA: LA-7. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN SMALL CELL CARCINOMA OF THE LUNG; Rev 08/30/00updated
  41. LUNG CARCINOMA: LA-10. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 CAPSULES IN NON--SMALL CELL LUNG CANCER; Rev 08/30/00updated
  42. NON-HODGKIN'S LYMPHOMA: LY-3. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN NON-HODGKIN'S LYMPHOMA; Rev 08/30/00updated; Rev 08/16/99
  43. NON-HODGKIN'S LYMPHOMA: LY-6. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN NON-HODGKIN'S LYMPHOMA, LOW GRADE; Rev 08/30/00updated
  44. NON-HODGKIN'S LYMPHOMA: LY-7. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN NON-HODGKIN'S LYMPHOMA, INTERMEDIATE GRADE; Rev 08/30/00updated
  45. NON-HODGKIN'S LYMPHOMA: LY-8. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN NON-HODGKIN'S LYMPHOMA, HIGH GRADE; Rev 08/30/00updated
  46. MANTLE ZONE LYMPHOMA: LY-9. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN MANTLE ZONE LYMPHOMA; Rev 08/30/00updated
  47. CHRONIC MYELOGENOUS LEUKEMIA: LY-10. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CHRONIC MYELOGENOUS LEUKEMIA; Rev 08/30/00updated
  48. MYCOSIS FUNGOIDES-SEZARY: LY-11. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN MYCOSIS FUNGOIDES-SEZARY SYNDROME; Rev 08/30/00updated
  49. LYMPHOMA: LY-12. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; Rev 08/30/00updated
  50. LYMPHOMA OF THE GASTROINTESTINAL TRACT: :LY-13. PHASE II STUDY OF ANTINEOPLASTONS A1- AND AS2-1 IN PRIMARY LYMPHOMA OF THE GASTROINTESTINAL TRACT; Rev 08/30/00updated
  51. CHRONIC LYMPHOCYTIC LEUKEMIA: LY-14. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 INFUSIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA; Rev 08/30/00updated
  52. MESOTHELIOMA: MA-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN MESOTHELIOMA; Rev 08/30/00updated
  53. MALIGNANT MELANOMA: ME-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN MALIGNANT MELANOMA; Rev 08/30/00updated
  54. MALIGNANT FIBROUS HSTIOCYTOMA: MF-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN MALIGNANT FIBROUS HISTIOCYTOMA; Rev 08/30/00updated
  55. MULTIPLE MYELOMA: MM-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN MULTIPLE MYELOMA; Rev 08/30/00updated
  56. MACROGLOBULINEMIA OF WALDENSTROM: MW-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN MACROGLOBULINEMIA OF WALDENSTROM; Rev 08/30/00updated
  57. NEUROBLASTOMA: NB-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN NEUROBLASTOMA; Rev Rev 08/30/00updated
  58. NEUROENDOCRINE TUMORS: NE-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN NEUROENDOCRINE TUMORS; Rev 08/30/00updated
  59. OVARY: OV-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CARCINOMA OF THE OVARY; Rev 08/30/00updated
  60. PANCREAS: PA-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CARCINOMA OF THE PANCREAS; Rev 08/30/00updated
  61. PNET OUTSIDE THE CNS: PN-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN PRIMITIVE NEUROECTODERMAL TUMOR OUTSIDE THE CENTRAL NERVOUS SYSTEM; Rev 08/30/00updated
  62. PROSTATE: PR-4. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADENOCARCINOMA OF THE PROSTATE; Rev 08/30/00updated
  63. PROSTATE: PR-5. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 CAPSULES IN ADENOCARCINOMA OF THE PROSTATE; Rev 08/30/00updated
  64. PROSTATE: PR-6. PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 CAPSULES IN COMBINATION WITH TOTAL ANDROGEN BLOCKADE IN PATIENTS WITH ADENOCARCINOMA OF THE PROSTATE; Rev 08/30/00updated
  65. PROSTATE: PR-8. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADENOCARCINOMA OF THE PROSTATE; Rev 08/30/00 updated
  66. KIDNEY: RN-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CARCINOMA OF THE KIDNEY; Rev 08/30/00updated
  67. SOFT TISSUE SARCOMA: SA-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN SOFT TISSUE SARCOMA; Rev 08/30/00updated
  68. SMALL INTESTINE: SI-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CARCINOMA OF THE SMALL INTESTINE; Rev 08/30/00updated
  69. STOMACH: ST-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADENOCARCINOMA OF THE STOMACH; Rev 08/30/00updated
  70. UTERINE CERVIX AND/OR VULVA: UC-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CARCINOMA OF THE UTERINE CERVIX AND/OR VULVA; Rev 08/30/00updated
  71. UNKNOWN PRIMARY SITE: UP-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CARCINOMA OF AN UNKNOWN PRIMARY; Rev 08/30/00updated
  72. WILMS' TUMOR: WT-2. PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADULTS WITH WILMS' TUMOR. Rev 08/30/00updated

Revised October 13, 2000


For more information, call 713-335-5697 or fax 713-335-5699.

Burzynski Research Institute
Suite 200
9432 Old Katy Road
Houston, TX 77055

Return to Home Page


Copyright ©1997 Burzynski Research Institute, Inc. All rights reserved.